U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254481) titled 'VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population' on Nov. 14.
Brief Summary: The purpose of this study is to evaluate the safety,tolerability,pharmacokinetics and pharmacodynamics of VB19055 in the healthy Chinese population.
Study Start Date: Oct. 05
Study Type: INTERVENTIONAL
Condition:
Hypertension
Intervention:
DRUG: VB19055
In this part, VB19055 tablets will be administered as a single or multiple oral dose.
DRUG: VB19055 placebo
In this part, VB19055 placebo tablets will be administered as a single or multiple oral dose.
Recruitment Status: RECRUITING
Sponsor: Z...